Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$60.03 - $76.49 $51,145 - $65,169
852 Added 7.99%
11,509 $878,000
Q4 2021

May 04, 2022

BUY
$47.97 - $62.21 $511,216 - $662,971
10,657 New
10,657 $641,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Offit Capital Advisors LLC Portfolio

Follow Offit Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Offit Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Offit Capital Advisors LLC with notifications on news.